PD-L2 drives resistance to EGFR-TKIs: dynamic changes of the tumor immune environment and targeted therapy.
Wang S, Su D, Chen H, Lai JC, Tang C, Li Y, Wang Y, Yang Y, Qin M, Jia L, Cui W, Yang J, Wang L, Wu C.
Wang S, et al. Among authors: qin m.
Cell Death Differ. 2024 May 30. doi: 10.1038/s41418-024-01317-2. Online ahead of print.
Cell Death Differ. 2024.
PMID: 38816578